Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.

Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB.

Am J Med Genet A. 2007 Mar 1;143A(5):443-8.

PMID:
17103437
2.

Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome.

Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB.

J Pediatr. 2004 Dec;145(6):744-9.

PMID:
15580194
3.

Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.

Whitman B, Carrel A, Bekx T, Weber C, Allen D, Myers S.

J Pediatr Endocrinol Metab. 2004 Apr;17(4):591-600.

PMID:
15198290
4.

Prader-Willi syndrome: how does growth hormone affect body composition and physical function?

Carrel AL, Allen DB.

J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1445-51. Review.

PMID:
11837498
6.
7.

Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.

Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Sep;69(3):443-51. doi: 10.1111/j.1365-2265.2008.03228.x. Epub 2008 Mar 18.

PMID:
18363884
8.
9.

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.

Carrel AL, Myers SE, Whitman BY, Allen DB.

J Clin Endocrinol Metab. 2002 Apr;87(4):1581-5.

PMID:
11932286
10.
11.

Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.

Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2008 Jun;68(6):919-25. Epub 2007 Nov 19.

PMID:
18031326
12.

Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably.

Lindgren AC, Hagenäs L, Müller J, Blichfeldt S, Rosenborg M, Brismar T, Ritzén EM.

Acta Paediatr. 1998 Jan;87(1):28-31.

PMID:
9510443
13.

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

Carrel AL, Myers SE, Whitman BY, Eickhoff J, Allen DB.

J Clin Endocrinol Metab. 2010 Mar;95(3):1131-6. doi: 10.1210/jc.2009-1389. Epub 2010 Jan 8.

14.

Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome.

Fillion M, Deal C, Van Vliet G.

J Pediatr. 2009 Feb;154(2):230-3. doi: 10.1016/j.jpeds.2008.07.058. Epub 2008 Sep 23.

PMID:
18814886
15.

Early manifestations of Prader-Willi syndrome: influence of growth hormone.

Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D.

J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1441-4.

PMID:
11837497
16.

Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.

Bakker NE, Siemensma EP, Koopman C, Hokken-Koelega AC.

Horm Res Paediatr. 2015;83(5):321-31. doi: 10.1159/000374113. Epub 2015 Feb 28.

PMID:
25764996
17.

Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.

Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Van Alfen AA, Van Leeuwen M, Van Wieringen H, Wegdam-den Boer ME, Zwaveling-Soonawala N, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2015 Apr;100(4):1609-18. doi: 10.1210/jc.2014-4347. Epub 2015 Feb 10.

PMID:
25668198
18.

Developmental profiles in young children with Prader-Labhart-Willi syndrome: effects of weight and therapy with growth hormone or coenzyme Q10.

Eiholzer U, Meinhardt U, Rousson V, Petrovic N, Schlumpf M, l'Allemand D.

Am J Med Genet A. 2008 Apr 1;146A(7):873-80. doi: 10.1002/ajmg.a.32137.

PMID:
18257095
19.

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.

de Lind van Wijngaarden RF, Siemensma EP, Festen DA, Otten BJ, van Mil EG, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Bocca G, Houdijk EC, Hoorweg-Nijman JJ, Vreuls RC, Jira PE, van Trotsenburg AS, Bakker B, Schroor EJ, Pilon JW, Wit JM, Drop SL, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2009 Nov;94(11):4205-15. doi: 10.1210/jc.2009-0454. Epub 2009 Oct 16.

PMID:
19837938

Supplemental Content

Support Center